https://www.selleckchem.com/pr....oducts/VX-680(MK-045
27±0.33 -0.60±0.35 D, 0.001), with a relative reduction of 55.0% in myopia progression. The increase in axial elongation in the atropine group was significantly less than control group (0.19±0.14 0.26±0.14 mm, 0.001), with a relative reduction of 26.9% in axial length. The 84.4% and 38.4% of the eyes progressed by less than 0.50 D and remained stable in the atropine group, compared with 51.7% and 4.2% in the control group. No adverse events were observed. Atropine sulphate eye gel 0.01% can slow down myopia progression a
Like
Comment
Share
